✦ LIBER ✦

First-in-human, phase I dose-escalation study of single and multiple doses of a first-in-class enhancer of fluoropyrimidines, a dUTPase inhibitor (TAS-114) in healthy male volunteers

✍ Scribed by Saito, Kaku; Nagashima, Hirotaka; Noguchi, Kazuharu; Yoshisue, Kunihiro; Yokogawa, Tatsushi; Matsushima, Eiji; Tahara, Takeshi; Takagi, Shigeru

Book ID: 121544945
Publisher: Springer
Year: 2014
Tongue: English
Weight: 447 KB
Volume: 73
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2383-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability and pharmacokinetics of ava

Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: A single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers

✍ Jinah Jung; Sangmin Choi; Sang Heon Cho; Jong-Lyul Ghim; Aekyung Hwang; Unjib Ki 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Safety and pharmacokinetics of PF-044479

Safety and pharmacokinetics of PF-04447943, a PDEA inhibitor, in single and multiple dose Phase 1 studies in healthy volunteers

✍ Rebecca M. Evans; Timothy Nicholas; Vu Le; Ruolun Qiu; William Martin; David Mar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Two first-in-human, open-label, phase I

Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers

✍ Barbara White; Francisco Leon; Wendy White; Gabriel Robbie 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 149 KB

A phase I, first-in-human dose-escalatio

A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors

✍ Raoul Tibes, Gil Fine, Gavin Choy, Sanjeev Redkar… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 232 KB

A phase I study of the pharmacokinetics,

A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteers

✍ Donald R. Tredway; Mauro Buraglio; George Hemsey; Geoff Denton 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 288 KB

A first-in-man phase I tolerability and

A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers

✍ D. Ross Camidge; Dominic Smethurst; Jim Growcott; Nigel C. Barrass; John R. Fost 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 324 KB